Germs on a plane - Infectious issues and the pediatric international traveler: What pediatricians should know

Pediatric Annals

Volumn 36, Issue 6, 2007, Pages 344-351

  Lee, Paul J ^a   Krilov, Leonard R ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOXA; ANTACID AGENT; ANTIBIOTIC AGENT; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; BISMUTH SALICYLATE; CHICKENPOX VACCINE; CHLOROQUINE; CIPROFLOXACIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DOXYCYCLINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; INFLUENZA VACCINE; MALARIA VACCINE; MEFLOQUINE; METRONIDAZOLE; NITAZOXANIDE; PNEUMOCOCCUS VACCINE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; TYPHOID VACCINE; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

ABDOMINAL DISCOMFORT; ABNORMAL DREAMING; AGGRESSION; AGITATION; ANXIETY DISORDER; ATAXIA; BLURRED VISION; BRAIN DISEASE; CHICKENPOX; CONFUSION; CRYPTOSPORIDIOSIS; DEPRESSION; DIZZINESS; ESOPHAGITIS; FEVER; GASTROINTESTINAL SYMPTOM; GIARDIASIS; HALLUCINATION; HEADACHE; HEPATITIS A; HEPATITIS B; HUMAN; INFECTION; INJECTION SITE REACTION; INSOMNIA; MALARIA; MALARIA CONTROL; MEASLES; MOOD CHANGE; NAUSEA; PANIC; PARANOIA; PARESTHESIA; PEDIATRICIAN; PHOTOSENSITIVITY; PRURITUS; PSORIASIS; RASH; RECOMMENDED DRUG DOSE; RESTLESSNESS; REVIEW; RISK BENEFIT ANALYSIS; ROTAVIRUS; SEIZURE; SIDE EFFECT; TRAVEL; TRAVELLER DIARRHEA; TREMOR; TUBERCULOSIS; URTICARIA; VAGINA CANDIDIASIS; VISUAL DISORDER; VOMITING;

EID: 34347262638     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20070601-10     Document Type: Review

References (23)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757.
2. Centers for Disease Control and Prevention (CDC). Notifiable Diseases/Deaths in Selected Cities Weekly Information (week 52). MMWR Morb Mortal Wkly Rep. 2006;55(52):1396-1407.
3. TravelIndustryReview.com. New Forms of Family Travel on the Rise This Summer says American Express Travel. Available online at http://www. travelindustryreview.com/news/1671. Accessed May 9, 2007.
4. Maloney SA, Weinberg M. Prevention of infectious diseases among international pediatric travelers: considerations for clinicians. Semin Pediatr Infect Dis. 2004;15(3):137-149.
5. Steffen R. Epidemiology of traveler's diarrhea. Clin Infect Dis. 2005;41 (Suppl 8):S536-S540.
6. Pitzinger B, Steffen R, Tschopp A. Incidence and clinical features of traveler's diarrhea in infants and children. Pediatr Infect Dis J. 1991;10(10):719-723.
7. Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. Am J Trop Med Hyg. 2000;62(5):585-589.
8. Mackell S. Traveler's diarrhea in the pediatric population: etiology and impact. Clin Infect Dis. 2005;41 (Suppl 8):S547-S552.
9. King CK, Glass R, Bresee JS, Duggan C. Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1-16.
10. Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med 1993;328(23):1653-1658.
11. Rendi-Wagner P, Kollaritsch H. Drug prophylaxis for travelers' diarrhea. Clin Infect Dis. 2002;34(5):628-633.
12. Briand V, Buffet P, Genty S, et al. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin Infect Dis. 2006;43(9):1170-1175.
13. Paton AW, Jennings MP, Morona R, et al. Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology 2005;128(5):1219-1228.
14. Huang DB, White AC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am. 2006;35(2): 291-314.
15. Huang DB, Chappell C, Okhuysen PC. Cryptosporidiosis in children. Semin Pediatr Infect Dis. 2004;15(4):253-259.
16. World Health Organization. International Travel and Health 2005: Vaccination Requirements and Health Advice. Geneva, Switzerland: World Health Organization;2005.
17. Summer AP, Stauffer WM, Fischer PR. Pediatric malaria in the developing world. Semin Pediatr Infect Dis. 2005;16(2):105-115.
18. Bledsoe GH. Malaria primer for clinicians in the United States. South Med J. 2005;98(12):1197-1204.
19. Girard MP, Reed ZH, Friede M, Kieny MP. A review of human vaccine research and development: malaria. Vaccine .2007;25(9):1567-1580.
20. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004;364(9443):1411-1420.
21. Moon TD, Oberhelman RA. Antiparasitic therapy in children. Pediatr Clin North Am 2005;52(3):917-948.
22. Postexposure prophylaxis, isolation, and quarantine to control an import-associated measles outbreak - Iowa, 2004.Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2004 Oct 22;53(41):969-71.
23. Guzman CA, Borsutzky S, Griot-Wenk M, et al. Vaccines against typhoid fever. Vaccine 2006;24(18):3804-3811.